203 related articles for article (PubMed ID: 29321566)
21. The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide.
Oba R; Igarashi A; Kamata M; Nagata K; Takano S; Nakagawa H
Eur J Neurosci; 2005 Feb; 21(3):733-40. PubMed ID: 15733091
[TBL] [Abstract][Full Text] [Related]
22. Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme.
Eckman EA; Adams SK; Troendle FJ; Stodola BA; Kahn MA; Fauq AH; Xiao HD; Bernstein KE; Eckman CB
J Biol Chem; 2006 Oct; 281(41):30471-8. PubMed ID: 16912050
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.
Kumar S; Singh S; Hinze D; Josten M; Sahl HG; Siepmann M; Walter J
J Biol Chem; 2012 Mar; 287(11):8641-51. PubMed ID: 22267728
[TBL] [Abstract][Full Text] [Related]
24. Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides.
Mohlake P; Whiteley CG
Mol Neurobiol; 2010 Jun; 41(2-3):149-58. PubMed ID: 20224908
[TBL] [Abstract][Full Text] [Related]
25. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
26. Protein processing mechanisms: from angiotensin-converting enzyme to Alzheimer's disease.
Hooper NM; Turner AJ
Biochem Soc Trans; 2000; 28(4):441-6. PubMed ID: 10961936
[TBL] [Abstract][Full Text] [Related]
27. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
[TBL] [Abstract][Full Text] [Related]
28. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.
Miners JS; Ashby E; Van Helmond Z; Chalmers KA; Palmer LE; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):181-93. PubMed ID: 17973905
[TBL] [Abstract][Full Text] [Related]
30. Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.
Zou K; Maeda T; Watanabe A; Liu J; Liu S; Oba R; Satoh Y; Komano H; Michikawa M
J Biol Chem; 2009 Nov; 284(46):31914-20. PubMed ID: 19773553
[TBL] [Abstract][Full Text] [Related]
31. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence.
Ehlers MR; Schwager SL; Scholle RR; Manji GA; Brandt WF; Riordan JF
Biochemistry; 1996 Jul; 35(29):9549-59. PubMed ID: 8755736
[TBL] [Abstract][Full Text] [Related]
32. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
33. Electrochemistry of Alzheimer Disease Amyloid Beta Peptides.
Chiorcea-Paquim AM; Enache TA; Oliveira-Brett AM
Curr Med Chem; 2018; 25(33):4066-4083. PubMed ID: 29446720
[TBL] [Abstract][Full Text] [Related]
34. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
35. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
36. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
[TBL] [Abstract][Full Text] [Related]
37. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
39. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
FASEB J; 2011 Sep; 25(9):2911-20. PubMed ID: 21593435
[TBL] [Abstract][Full Text] [Related]
40. Roles of the juxtamembrane and extracellular domains of angiotensin-converting enzyme in ectodomain shedding.
Pang S; Chubb AJ; Schwager SL; Ehlers MR; Sturrock ED; Hooper NM
Biochem J; 2001 Aug; 358(Pt 1):185-92. PubMed ID: 11485566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
